Novavax (NVAX) PT Raised to $38.50 at Oppenheimer
Oppenheimer analyst Kevin DeGeeter raised ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
